Related Experiment Videos
Genetics and pathogenesis of malignant hyperthermia
K Jurkat-Rott1, T McCarthy, F Lehmann-Horn
1Department of Applied Physiology, University of Ulm, D-89081 Ulm, Germany.
Muscle & Nerve
|December 11, 1999
Summary
Malignant hyperthermia (MH) is a severe reaction to anesthesia, often linked to the ryanodine receptor gene. Genetic research is uncovering the complex molecular causes of this condition.
Area of Science:
- Genetics
- Anesthesiology
- Molecular Biology
Background:
- Malignant hyperthermia (MH) is a critical, life-threatening condition triggered by anesthetic agents.
- It involves uncontrolled skeletal muscle calcium release, leading to systemic failure.
- Susceptibility is often an autosomal dominant trait, sometimes associated with myopathies, but usually asymptomatic outside anesthesia.
Purpose of the Study:
- To explore the genetic heterogeneity and molecular etiology of Malignant hyperthermia.
- To understand the role of specific genes, like the ryanodine receptor, in MH susceptibility.
- To review current knowledge on the mechanisms of excitation-contraction coupling in MH.
Main Methods:
- Diagnosis relies on the in vitro contracture test (IVCT) using skeletal muscle biopsy.
- Genetic linkage analysis has identified over 20 mutations in the ryanodine receptor gene.
- Research involves heterologous expression systems to functionally characterize disease-causing mutations.
Main Results:
- Over 50% of MH families show linkage to the ryanodine receptor gene.
- More than 20 mutations within this gene are associated with MH.
- At least five other genetic loci are implicated, indicating significant genetic heterogeneity.
Conclusions:
- The ryanodine receptor gene plays a major role in MH, but other genes are also involved.
- Understanding the molecular basis of MH is advancing through research on excitation-contraction coupling.
- Functional studies of mutations are crucial for elucidating the molecular etiology of MH.